ICYMI: Data find provider consolidation increases health care costs
Two recent studies demonstrate how increases in consolidation drive up health care costs and raise concerns with Medicare Part B demo.
Two recent studies demonstrate how increases in consolidation drive up health care costs and raise concerns with Medicare Part B demo.
There is a growing body of research on the impact of health care provider consolidation on overall health care spending. In case you missed it, a recent issue brief from the National Institute for Health Care Management (NIHCM) Foundation and a study from the Community Oncology Alliance (COA) again demonstrate how increases in consolidation drive up health care costs.
The findings of these studies raise additional concerns when it comes to the proposed Medicare Part B Drug Payment model. The proposed Part B Drug Payment model would make it more difficult for community practices to offer lifesaving specialty treatments to cancer patients and other patients in need. As a result, Drs. Cliff Hudis and Daniel Hayes of the American Society of Clinical Oncology last month wrote in The Hill, the Part B demonstration “might even threaten the dwindling supply of community oncology practices.”
Patient health and wellbeing must be a priority, but unfortunately the proposed Part B experiment could put patient health at risk by increasing consolidation and decreasing access to care.
Learn more about the government proposed Medicare payment change here and more on Medicare Part B at PhRMA.org/PartB.